Medicinova Inc financial data

Symbol
MNOV on Nasdaq
Industry
Pharmaceutical Preparations
Location
4275 Executive Square, Suite 300, La Jolla, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 19, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.68K % -8.53%
Debt-to-equity 5.56 % +0.91%
Return On Equity -19.7 % -49.1%
Return On Assets -18.6 % -49%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 49M shares 0%
Common Stock, Shares, Outstanding 49M shares 0%
Entity Public Float 68.6M USD -37.3%
Common Stock, Value, Issued 49K USD 0%
Weighted Average Number of Shares Outstanding, Basic 49M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 49M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1M USD
Research and Development Expense 6.8M USD +28.3%
General and Administrative Expense 5.48M USD +4.54%
Operating Income (Loss) -12.7M USD -28%
Net Income (Loss) Attributable to Parent -11M USD -28.9%
Earnings Per Share, Basic -0.23 USD/shares -35.3%
Earnings Per Share, Diluted -0.23 USD/shares -35.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 40.4M USD -20.9%
Accounts Receivable, after Allowance for Credit Loss, Current 1M USD
Assets, Current 41.1M USD -19.7%
Property, Plant and Equipment, Net 25.5K USD -44.3%
Operating Lease, Right-of-Use Asset 357K USD -38%
Goodwill 9.6M USD 0%
Other Assets, Noncurrent 19K USD -74.4%
Assets 55.9M USD -15.7%
Accounts Payable, Current 1.1M USD +9.82%
Employee-related Liabilities, Current 786K USD -4.66%
Liabilities, Current 2.96M USD -9.76%
Deferred Income Tax Liabilities, Net 202K USD 0%
Operating Lease, Liability, Noncurrent 211K USD -48.5%
Other Liabilities, Noncurrent 211K USD -48.5%
Liabilities 3.37M USD -13.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -135K USD -14.5%
Retained Earnings (Accumulated Deficit) -427M USD -2.66%
Stockholders' Equity Attributable to Parent 52.5M USD -15.8%
Liabilities and Equity 55.9M USD -15.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.87M USD -21.7%
Net Cash Provided by (Used in) Investing Activities 39.9K USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 49M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.86M USD -111%
Deferred Tax Assets, Valuation Allowance 84.4M USD +1.24%
Deferred Tax Assets, Gross 85.6M USD +1.15%
Operating Lease, Liability 405K USD -35.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -11.1M USD -29.1%
Lessee, Operating Lease, Liability, to be Paid 448K USD -37.7%
Property, Plant and Equipment, Gross 428K USD -12.5%
Operating Lease, Liability, Current 194K USD -10.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 206K USD -10%
Lessee, Operating Lease, Liability, to be Paid, Year One 224K USD -15.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 42.6K USD -53.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 17.3K USD -91.6%
Deferred Tax Assets, Operating Loss Carryforwards 71.2M USD +1.69%
Unrecognized Tax Benefits 2.7M USD +69.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 17.3K USD -91.6%
Operating Lease, Payments 261K USD +1.46%
Depreciation, Depletion and Amortization 5.35K USD +30.3%
Share-based Payment Arrangement, Expense 1.19M USD +67.7%